TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
陳晉興CHEN, JIN-SHING
- 計畫主持人
- 執行臨床試驗年資 22 年 9 個月
發表文獻
60筆
11
Ye JR, Chen PH, Chuang JH, Lin MW, Tsai TM, Hsu HH, Chen JS. Treatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA-IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Study. Front Surg. 2022 Mar 11;9:816018. doi: 10.3389/fsurg.2022.816018. PMID: 35360423; PMCID: PMC8961802.
12
Chen PH, Kuo SW, Chen JS. ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor. Ann Surg Oncol. 2022 Aug;29(8):4885-4886. doi: 10.1245/s10434-022-11487-3. Epub 2022 Mar 21. PMID: 35312900.
13
Lin YJ, Chiang XH, Lu TP, Hsieh MS, Lin MW, Hsu HH, Chen JS. Thoracoscopic Lobectomy Versus Sublobar Resection for pStage I Geriatric Non-Small Cell Lung Cancer. Front Oncol. 2022 Jan 24;11:777590. doi: 10.3389/fonc.2021.777590. PMID: 35141143; PMCID: PMC8818756.
14
Chen Y, Yang WH, Chen HF, Huang LM, Gao JY, Lin CW, Wang YC, Yang CS, Liu YL, Hou MH, Tsai CL, Chou YZ, Huang BY, Hung CF, Hung YL, Wang WJ, Su WC, Kumar V, Wu YC, Chao SW, Chang CS, Chen JS, Chiang YP, Cho DY, Jeng LB, Tsai CH, Hung MC. Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2. J Biol Chem. 2022 Mar;298(3):101658. doi: 10.1016/j.jbc.2022.101658. Epub 2022 Jan 29. PMID: 35101449; PMCID: PMC8800562.
15
Chen LW, Lin MW, Hsieh MS, Yang SM, Wang HJ, Chen YC, Chen HY, Hu YH, Lee CE, Chen JS, Chang YC, Chen CM. Radiomic Values from High-Grade Subtypes to Predict Spread Through Air Spaces in Lung Adenocarcinoma. Ann Thorac Surg. 2022 Sep;114(3):999-1006. doi: 10.1016/j.athoracsur.2021.07.075. Epub 2021 Aug 27. PMID: 34454902.
16
Huang YS, Niisato E, Su MM, Benkert T, Chien N, Chiang PY, Lee WJ, Chen JS, Chang YC. Applying Compressed Sensing Volumetric Interpolated Breath-Hold Examination and Spiral Ultrashort Echo Time Sequences for Lung Nodule Detection in MRI. Diagnostics (Basel). 2021 Dec 31;12(1):93. doi: 10.3390/diagnostics12010093. PMID: 35054260; PMCID: PMC8774698.
17
Wang HJ, Lin MW, Chen YC, Chen LW, Hsieh MS, Yang SM, Chen HF, Wang CW, Chen JS, Chang YC, Chen CM. A radiomics model can distinguish solitary pulmonary capillary haemangioma from lung adenocarcinoma. Interact Cardiovasc Thorac Surg. 2022 Feb 21;34(3):369-377. doi: 10.1093/icvts/ivab271. PMID: 34648631; PMCID: PMC8860424.
18
Chang CC, Hsieh MS, Lin MW, Lee YH, Hsiao YJ, Su KY, Su TJ, Yu SL, Chen JS. Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes. Biomolecules. 2022 Jan 19;12(2):160. doi: 10.3390/biom12020160. PMID: 35204661; PMCID: PMC8961607.
19
Wang YW, Chen CJ, Wang TC, Huang HC, Chen HM, Shih JY, Chen JS, Huang YS, Chang YC, Chang RF. Multi-energy level fusion for nodal metastasis classification of primary lung tumor on dual energy CT using deep learning. Comput Biol Med. 2022 Feb;141:105185. doi: 10.1016/j.compbiomed.2021.105185. Epub 2021 Dec 29. PMID: 34986453.
20
Chiang XH, Lu TP, Hsieh MS, Tsai TM, Liao HC, Kao TN, Chang CH, Lin MW, Hsu HH, Chen JS. Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma. Ann Surg Oncol. 2021 Dec;28(13):8398-8411. doi: 10.1245/s10434-021-10213-9. Epub 2021 Jun 18. PMID: 34145505.
